Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
Completed
Alcon Research
Phase 3
2010-08-01
The primary objective of this study was to compare the safety and efficacy of Durezol™
compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a
pediatric population 0 to 3 years of age.
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
Completed
Alcon Research
Phase 3
2010-10-01
The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times
daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of
endogenous anterior uveitis.
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
Completed
Alcon Research
Phase 4
2009-03-01
The purpose of this clinical research study is to investigate the efficacy of predosing
patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic
emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal
thickness.
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
Completed
Parsons Medical Communications
Phase 4
2009-03-01
The purpose of this clinical research study is to investigate the efficacy of predosing
patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic
emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal
thickness.
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
Completed
Sirion Therapeutics, Inc.
Phase 4
2009-03-01
The purpose of this clinical research study is to investigate the efficacy of predosing
patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic
emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal
thickness.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
